Targeting Immunometabolism in Glioblastoma
We have only recently begun to understand how cancer metabolism affects antitumor responses and immunotherapy outcomes. Certain immunometabolic targets have been actively pursued in other tumor types, however, glioblastoma research has been slow to exploit the therapeutic vulnerabilities of immunome...
Main Authors: | Aditya A. Mohan, William H. Tomaszewski, Aden P. Haskell-Mendoza, Kelly M. Hotchkiss, Kirit Singh, Jessica L. Reedy, Peter E. Fecci, John H. Sampson, Mustafa Khasraw |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.696402/full |
Similar Items
-
Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
by: Eric Fox, et al.
Published: (2018-09-01) -
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
by: Andrea M. Chambers, et al.
Published: (2018-11-01) -
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
by: Lijie Zhai, et al.
Published: (2020-06-01) -
Immunometabolism of lymphocytes and its changes in experimental diabetes mellitus
by: A. M. Kamyshny, et al.
Published: (2016-12-01) -
Immunometabolism of Macrophages in Bacterial Infections
by: Gaël Galli, et al.
Published: (2021-01-01)